Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris C Wood

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|September 23, 2015
Mapping the Pathways of Resistance to Targeted TherapiesKris C Wood
Nature Communications|January 29, 2020
Overcoming MCL-1-driven adaptive resistance to targeted therapiesKris C Wood
Nature Genetics|September 25, 2023
Hyperactivation of oncogenic driver pathways as a precision therapeutic strategyKris C Wood
Nature Chemical Biology|March 25, 2022
Drivers of intrinsic resistanceKris C Wood
Science Translational Medicine|January 27, 2017
Suppressing oncogenic transcription with a little healthy competitionKris C Wood
Science Translational Medicine|December 9, 2016
An EXITS strategy for decreasing cancer risk in womenKris C Wood
Cell Stem Cell|September 8, 2009
Growth signaling at the nexus of stem cell life and deathKris C Wood, David M Sabatini
Trends in Cancer|June 7, 2023
Endogenous and imposed determinants of apoptotic vulnerabilities in cancerKristopher A Sarosiek, Kris C Wood
Trends in Cancer|May 1, 2018
Mapping Effector-Phenotype Landscapes in KRAS-Driven CancersPeter S Winter, Kris C Wood
Genes & Cancer|October 15, 2016
Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesKatherine R Singleton, Kris C Wood
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|September 23, 2015
Mapping the Pathways of Resistance to Targeted TherapiesKris C Wood
Nature Communications|January 29, 2020
Overcoming MCL-1-driven adaptive resistance to targeted therapiesKris C Wood
Nature Genetics|September 25, 2023
Hyperactivation of oncogenic driver pathways as a precision therapeutic strategyKris C Wood
Nature Chemical Biology|March 25, 2022
Drivers of intrinsic resistanceKris C Wood
Science Translational Medicine|January 27, 2017
Suppressing oncogenic transcription with a little healthy competitionKris C Wood
Science Translational Medicine|December 9, 2016
An EXITS strategy for decreasing cancer risk in womenKris C Wood
Cell Stem Cell|September 8, 2009
Growth signaling at the nexus of stem cell life and deathKris C Wood, David M Sabatini
Trends in Cancer|June 7, 2023
Endogenous and imposed determinants of apoptotic vulnerabilities in cancerKristopher A Sarosiek, Kris C Wood
Trends in Cancer|May 1, 2018
Mapping Effector-Phenotype Landscapes in KRAS-Driven CancersPeter S Winter, Kris C Wood
Genes & Cancer|October 15, 2016
Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesKatherine R Singleton, Kris C Wood
Pageof 8